A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy

A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy

Sio Teng Lam,1,2,* He Huang,1,* Xiaojie Fang,1 Zhao Wang,1 Huangming Hong,3 Quanguang Ren,1 Ying Tian,1 Suxia Lin,4 Tongyu Lin1 1Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, and Collaborative Innovation Center of Cancer Med...

Full description

Bibliographic Details
Main Authors: Lam ST, Huang H, Fang X, Wang Z, Hong H, Ren Q, Tian Y, Lin S, Lin T
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Cancer Management and Research
Subjects:
extranodal natural killer/t-cell lymphoma
pd-l1
foxp3+tregs
prognosis
Online Access:https://www.dovepress.com/a-new-immunological-prognostic-model-based-on-immunohistochemistry-for-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/a-new-immunological-prognostic-model-based-on-immunohistochemistry-for-peer-reviewed-article-CMAR

Similar Items